Dionysios Metaxas
Research Subjects
Dionysios Metaxas has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Antonios Koutras
Department of Obstetrics and Gynecology, Alexandra Maternity Hospital of Athens, National Kapodistrian University of Athens, Lourou 4, 11528 Athens, Greece
2 shared publications - Athanasios Chionis
Department of Gynecology, Laiko General Hospital of Athens, 11527 Athens, Greece
2 shared publications - Emmanouil Andreou
Department of Gynecology, Laiko General Hospital of Athens, 11527 Athens, Greece
2 shared publications - Emmanuel N. Kontomanolis
Department of Obstetrics and Gynecology, Democritus University of Thrace, 68100 Alexandroupolis, Greece
2 shared publications - Ioakeim Sapantzoglou
1st Department of Obstetrics and Gynecology, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece
2 shared publications - Ioannis Prokopakis
1st Department of Obstetrics and Gynecology, National and Kapodistrian University of Athens, General Hospital of Athens ‘ALEXANDRA’, 11528 Athens, Greece
2 shared publications
Latest Publications
- Open Access
- 23 November 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (23) , 8322
Unveiling the Diagnostic and Prognostic Value of Inflammatory Cytokines in Preeclampsia: A Review of Ιnterleukins IL-15, IL-16, IL-17 and IL-35
Background: Preeclampsia (PE) is a multicomplex disorder occurring during pregnancy, characterized by the onset of hypertension and proteinuria, or hypertension accompanied by organ dysfunction (such as impaired liver function, renal insufficiency, pulmonary edema, or cerebral and visual impairment), with or without proteinuria in the latter half of pregnancy or postpartum. It impacts around 5% of all pregnancies, resulting in considerable fetal and maternal mortality and morbidity. A properly regulated inflammatory response is crucial for achieving a successful pregnancy; nevertheless, an excessive reaction appears to contribute to the onset of this syndrome. This review sought to investigate the role and correlation of interleukins (IL)-15, IL-16, IL-17, and IL-35 in the pathogenesis of PE, along with the prospective application of biomarkers in predicting and monitoring this illness. Methods: A thorough investigation was performed in the PubMed/Medline, Scopus, and Google Scholar electronic databases up to September 2025, employing the terms PE, Pregnancy, IL-15, IL-16, IL-17, IL-35, Inflammatory Response, and Cytokines. Women at the time of diagnosis were matched with normotensive counterparts of similar gestational age. Results: A total of 30 full-text articles were obtained following a thorough assessment. The majority of the published data showed that women with preeclampsia have significantly higher levels of IL-15 and IL-17 in their plasma compared to normotensive women, whereas IL-35 levels were mainly decreased, respectively. Moreover, IL-16 levels were elevated across all the studies, primarily correlating with condition severity. Conclusions: Collectively, IL-15, IL-16, IL-17, and IL-35 are markedly linked to the immunopathology of preeclampsia, with elevated maternal serum levels corresponding with the presence and severity of the disease. These cytokines demonstrate potential as biomarkers for diagnosis, prognosis, and disease surveillance. Future study, including the examination of cytokine profiles in placental and amniotic fluid, as well as additional intriguing cytokines, is essential to clarify their prognostic importance and mechanistic roles.
- 23 November 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (23) , 8322
Open AccessUnveiling the Diagnostic and Prognostic Value of Inflammatory Cytokines in Preeclampsia: A Review of Ιnterleukins IL-15, IL-16, IL-17 and IL-35
Background: Preeclampsia (PE) is a multicomplex disorder occurring during pregnancy, characterized by the onset of hypertension and proteinuria, or hypertension accompanied by organ dysfunction (such as impaired liver function, renal insufficiency, pulmonary edema, or cerebral and visual impairment), with or without proteinuria in the latter half of pregnancy or postpartum. It impacts around 5% of all pregnancies, resulting in considerable fetal and maternal mortality and morbidity. A properly regulated inflammatory response is crucial for achieving a successful pregnancy; nevertheless, an excessive reaction appears to contribute to the onset of this syndrome. This review sought to investigate the role and correlation of interleukins (IL)-15, IL-16, IL-17, and IL-35 in the pathogenesis of PE, along with the prospective application of biomarkers in predicting and monitoring this illness. Methods: A thorough investigation was performed in the PubMed/Medline, Scopus, and Google Scholar electronic databases up to September 2025, employing the terms PE, Pregnancy, IL-15, IL-16, IL-17, IL-35, Inflammatory Response, and Cytokines. Women at the time of diagnosis were matched with normotensive counterparts of similar gestational age. Results: A total of 30 full-text articles were obtained following a thorough assessment. The majority of the published data showed that women with preeclampsia have significantly higher levels of IL-15 and IL-17 in their plasma compared to normotensive women, whereas IL-35 levels were mainly decreased, respectively. Moreover, IL-16 levels were elevated across all the studies, primarily correlating with condition severity. Conclusions: Collectively, IL-15, IL-16, IL-17, and IL-35 are markedly linked to the immunopathology of preeclampsia, with elevated maternal serum levels corresponding with the presence and severity of the disease. These cytokines demonstrate potential as biomarkers for diagnosis, prognosis, and disease surveillance. Future study, including the examination of cytokine profiles in placental and amniotic fluid, as well as additional intriguing cytokines, is essential to clarify their prognostic importance and mechanistic roles.
- Open Access
- 26 August 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (17) , 6031
Pregnancy-Related Acute Kidney Injury: Causes and Its Impact on Perinatal Outcomes—A Systematic Review
Background: Pregnancy-Related Acute kidney injury (PRAKI) is a critical complication of pregnancy, defined by the sudden deterioration in renal function during gestation or within the initial six weeks postpartum. Pregnancy is thought to increase the risk of acute kidney injury (AKI) by 51%. This is linked to the anatomical alterations that occur during pregnancy and special conditions, such as preeclampsia/eclampsia. PRAKI’s epidemiology and outcome vary between developed and developing nations. PRAKI is an uncommon entity in high-income countries; however, its incidence has recently increased. The aim of this systematic review is to evaluate the maternal and perinatal outcomes and risk factors affecting pregnancies affected by AKI. Methods: Comprehensive research was performed in PubMed/Medline, Scopus, and Google Scholar electronic databases from 2015 up to January 2025, using the terms AKI, PRAKI, sepsis, preeclampsia/eclampsia, liver enzymes, low platelet count (HELLP) syndrome, and pregnancy. After a thorough assessment, 25 full-text articles were obtained. Results: Our results revealed that preeclampsia, eclampsia, HELLP syndrome, and antepartum and postpartum hemorrhage predispose women to PRAKI. Other unusual factors, like disseminated intravascular coagulation (DIC) or hemolytic uremic syndrome (HUS), should not be underestimated. Furthermore, the latest published data showed unfavorable maternal and fetal outcomes in pregnancies affected by AKI compared to the general population. Conclusions: PRAKI constitutes a serious pregnancy complication that requires immediate treatment. The higher prevalence of PRAKI in developing countries (4–26%) versus wealthy nations (1.0–2.8%) has considerably indicated the impact of socioeconomic status and the accessibility of health services.
- 26 August 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (17) , 6031
Open AccessPregnancy-Related Acute Kidney Injury: Causes and Its Impact on Perinatal Outcomes—A Systematic Review
Background: Pregnancy-Related Acute kidney injury (PRAKI) is a critical complication of pregnancy, defined by the sudden deterioration in renal function during gestation or within the initial six weeks postpartum. Pregnancy is thought to increase the risk of acute kidney injury (AKI) by 51%. This is linked to the anatomical alterations that occur during pregnancy and special conditions, such as preeclampsia/eclampsia. PRAKI’s epidemiology and outcome vary between developed and developing nations. PRAKI is an uncommon entity in high-income countries; however, its incidence has recently increased. The aim of this systematic review is to evaluate the maternal and perinatal outcomes and risk factors affecting pregnancies affected by AKI. Methods: Comprehensive research was performed in PubMed/Medline, Scopus, and Google Scholar electronic databases from 2015 up to January 2025, using the terms AKI, PRAKI, sepsis, preeclampsia/eclampsia, liver enzymes, low platelet count (HELLP) syndrome, and pregnancy. After a thorough assessment, 25 full-text articles were obtained. Results: Our results revealed that preeclampsia, eclampsia, HELLP syndrome, and antepartum and postpartum hemorrhage predispose women to PRAKI. Other unusual factors, like disseminated intravascular coagulation (DIC) or hemolytic uremic syndrome (HUS), should not be underestimated. Furthermore, the latest published data showed unfavorable maternal and fetal outcomes in pregnancies affected by AKI compared to the general population. Conclusions: PRAKI constitutes a serious pregnancy complication that requires immediate treatment. The higher prevalence of PRAKI in developing countries (4–26%) versus wealthy nations (1.0–2.8%) has considerably indicated the impact of socioeconomic status and the accessibility of health services.
- Open Access
- 10 February 2023
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14, 1134587
Case report: The devil was hidden in the mastocytes – an unusually fulminant case of indolent systemic mastocytosis in a 45-year-old patient, missed for almost 20 years
Indolent systemic mastocytosis (ISM) represents the most common form of SM, typically following a slow clinical course. While anaphylactic reactions may come up in the life course of an ISM patient, these are often moderate and do not pose a threat to patient’s health. Here, we present an undiagnosed case of ISM with recurrent severe anaphylactic episodes following consumption of food and emotional stress. One of these episodes led to anaphylactic shock, necessitating temporary mechanical ventilation and intensive care unit (ICU) support. Besides hypotension, a diffuse, itchy, red rash was the only notable clinical finding. Upon recovery, we found abnormally high baseline serum tryptase level as well as 10% bone marrow (BM) infiltration by multifocal, dense clusters of CD117+/mast cell tryptase+/CD25+ mast cells (MCs), consolidating the diagnosis of ISM. Prophylactic treatment with a histamine receptor antagonist was initiated, resulting in milder episodes thereafter. Diagnosis of ISM requires a high level of suspicion; its prompt recognition and treatment are important in preventing potentially life-threatening anaphylactic episodes.
- 10 February 2023
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14, 1134587
Open AccessCase report: The devil was hidden in the mastocytes – an unusually fulminant case of indolent systemic mastocytosis in a 45-year-old patient, missed for almost 20 years
Indolent systemic mastocytosis (ISM) represents the most common form of SM, typically following a slow clinical course. While anaphylactic reactions may come up in the life course of an ISM patient, these are often moderate and do not pose a threat to patient’s health. Here, we present an undiagnosed case of ISM with recurrent severe anaphylactic episodes following consumption of food and emotional stress. One of these episodes led to anaphylactic shock, necessitating temporary mechanical ventilation and intensive care unit (ICU) support. Besides hypotension, a diffuse, itchy, red rash was the only notable clinical finding. Upon recovery, we found abnormally high baseline serum tryptase level as well as 10% bone marrow (BM) infiltration by multifocal, dense clusters of CD117+/mast cell tryptase+/CD25+ mast cells (MCs), consolidating the diagnosis of ISM. Prophylactic treatment with a histamine receptor antagonist was initiated, resulting in milder episodes thereafter. Diagnosis of ISM requires a high level of suspicion; its prompt recognition and treatment are important in preventing potentially life-threatening anaphylactic episodes.